Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
PKN3 inhibitor compound 16 is an inhibitor of serine/threonine protein kinase N3 (IC50 = 14 nM).1 It is selective for this kinase over a panel of 234 kinases but does inhibit serine/threonine protein kinase NLK, activin receptor type 1 (ACTR1), and receptor-interacting serine/threonine kinase 2 (RIPK2) at 1 µM, as well as cyclin G-associated kinase (GAK; IC50 = 74 nM in a bioluminescence resonance energy transfer (BRET) assay).1,2 PKN3 inhibitor compound 16 inhibits viral replication in dengue virus-infected Huh7 cells (EC50 = 3.6 µM) without inducing cell death with a 50% cytotoxic concentration (CC50) value of >10 µM.3
WARNING This product is not for human or veterinary use.
1. Identification of 4-
2. Design and analysis of the 4-
3. Potent antiviral activity of novel multi-